Short- and long-term functional consequences of fluoxetine exposure during adolescence in male rats
- PMID: 20172503
- PMCID: PMC2868075
- DOI: 10.1016/j.biopsych.2009.12.033
Short- and long-term functional consequences of fluoxetine exposure during adolescence in male rats
Abstract
Background: Fluoxetine (FLX), a selective serotonin reuptake inhibitor, is prescribed for the treatment of major depressive disorder in young populations. Here, we explore the short- and long-term consequences of adolescent exposure to FLX on behavioral reactivity to emotion-eliciting stimuli.
Methods: Adolescent male rats received FLX (10 mg/kg) twice daily for 15 consecutive days (postnatal days 35-49). The influence of FLX on behavioral reactivity to rewarding and aversive stimuli was assessed 24 hours (short-term) or 3 weeks after FLX treatment (long-term). A separate group of adult rats was also treated with FLX (postnatal days 65-79) and responsiveness to forced swimming was assessed at identical time intervals as with the adolescents.
Results: Fluoxetine exposure during adolescence resulted in long-lasting decreases in behavioral reactivity to forced swimming stress and enhanced sensitivity to sucrose and to anxiety-eliciting situations in adulthood. The FLX-induced anxiety-like behavior was alleviated by re-exposure to FLX in adulthood. Fluoxetine treatment during adolescence also impaired sexual copulatory behaviors in adulthood. Fluoxetine-treated adult rats did not show changes in behavioral reactivity to forced swim stress as observed in those treated during adolescence and tested in adulthood.
Conclusions: Treating adolescent rats with FLX results in long-lived complex outputs regulated by the emotional valence of the stimulus, the environment in which it is experienced, and the brain circuitry likely being engaged by it. Our findings highlight the need for further research to improve our understanding of the alterations that psychotropic exposure may induce on the developing nervous system and the potential enduring effects resulting from such treatments.
Copyright 2010 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
The authors report no biomedical financial interests or potential conflicts of interest.
Figures
References
-
- Kapornai K, Vetro A. Depression in children. Curr Opin Psychiatry. 2008;21:1–7. - PubMed
-
- Birmaher B, Ryan ND, Williamson DE, Brent DA, Kaufman J, Dahl RE, et al. Childhood and adolescent depression: A review of the past 10 years. Part I. J Am Acad Child Adolesc Psychiatry. 1996;35:1427–1439. - PubMed
-
- Weissman MM, Wolk S, Goldstein RB, Moreau D, Adams P, Greenwald S, et al. Depressed adolescents grown up. JAMA. 1999;281:1707–1713. - PubMed
-
- Pfeffer CR. Diagnosis of childhood and adolescent suicidal behavior: Unmet needs for suicide prevention. Biol Psychiatry. 2001;49:1055–1061. - PubMed
-
- Rihmer Z. Suicide risk in mood disorders. Curr Opin Psychiatry. 2007;20:17–22. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
